Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 105.25%2.42B | 14.67%1.33B | 59.47%1.21B | 20.34%4.49B | 39.62%1.39B | 4.70%1.18B | 39.30%1.16B | -2.06%760M | 7.21%3.73B | 25.41%997M |
| Net income from continuing operations | 144.10%1.9B | 98.11%1.26B | 60.37%781M | 58.12%3.09B | 98.83%1.19B | 33.33%780M | 26.29%634M | 81.04%487M | 92.04%1.95B | 173.16%597M |
| Operating gains losses | -748.94%-399M | -622.81%-824M | -85.71%-65M | 53.11%-234M | 89.73%-38M | -14.63%-47M | -60.56%-114M | -105.88%-35M | 25.63%-499M | -6.02%-370M |
| Depreciation and amortization | -3.56%460M | -9.17%436M | -13.29%411M | -6.27%1.92B | -14.18%484M | -5.36%477M | 0.00%480M | -4.24%474M | 2.30%2.04B | -6.62%564M |
| Asset impairment expenditure | -50.00%3M | --0 | -83.87%5M | -220.17%-423M | -250.32%-469M | -14.29%6M | -60.87%9M | 210.00%31M | -79.74%352M | -81.33%312M |
| Remuneration paid in stock | 96.00%98M | 440.00%27M | 223.08%42M | -1.52%65M | -111.54%-3M | 233.33%50M | -16.67%5M | -31.58%13M | 20.00%66M | 13.04%26M |
| Deferred tax | 93.90%477M | -78.21%102M | 59.77%278M | 76.54%1.52B | 263.22%632M | 12.84%246M | 77.27%468M | -15.12%174M | 29.67%861M | 232.82%174M |
| Other non cashItems | -211.27%-79M | 1,916.98%963M | 114.71%10M | -162.26%-139M | -140.54%-89M | 231.48%71M | -89.29%-53M | -203.03%-68M | -307.69%-53M | -140.22%-37M |
| Change In working capital | 173.31%184M | -215.18%-129M | 56.43%-105M | 5.45%-382M | 98.59%-2M | -560.53%-251M | 439.39%112M | -26.18%-241M | -25.47%-404M | -35.24%-142M |
| -Change in receivables | 261.27%279M | -2,420.00%-252M | 20.00%-48M | 22.56%-302M | 72.04%-59M | -188.33%-173M | 88.10%-10M | -1,100.00%-60M | -538.20%-390M | -283.64%-211M |
| -Change in inventory | 1.45%-68M | -95.00%2M | -139.29%-67M | -77.32%-172M | -542.31%-115M | -43.75%-69M | 1,433.33%40M | 61.11%-28M | 55.71%-97M | 130.23%26M |
| -Change in payables and accrued expense | -381.82%-53M | -29.67%64M | 82.98%-24M | 229.73%48M | 2,280.00%109M | -168.75%-11M | 28.17%91M | -18.49%-141M | -139.78%-37M | -106.49%-5M |
| -Change in other current assets | -116.67%-1M | -25.00%-15M | -100.00%-2M | -33.71%59M | 135.71%66M | -81.25%6M | -50.00%-12M | 75.00%-1M | 134.10%89M | 255.56%28M |
| -Change in other current liabilities | 775.00%27M | 2,300.00%72M | 427.27%36M | -148.39%-15M | -115.00%-3M | -118.18%-4M | 133.33%3M | -450.00%-11M | 229.17%31M | 186.96%20M |
| Interest paid (cash flow from operating activities) | 76.32%-18M | 12.98%-114M | 7.41%-25M | -26.67%-380M | -25.86%-146M | -145.16%-76M | -0.77%-131M | -17.39%-27M | 1.64%-300M | 10.77%-116M |
| Interest received (cash flow from operating activities) | -19.70%53M | -26.00%37M | -32.35%46M | 0.00%237M | -33.75%53M | 15.79%66M | -1.96%50M | 38.78%68M | 166.29%237M | 116.22%80M |
| Tax refund paid | -83.80%-261M | -41.20%-425M | -43.10%-166M | -48.09%-776M | -138.46%-217M | -49.47%-142M | -29.74%-301M | -9.43%-116M | 31.68%-524M | 9.90%-91M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 105.25%2.42B | 14.67%1.33B | 59.47%1.21B | 20.34%4.49B | 39.62%1.39B | 4.70%1.18B | 39.30%1.16B | -2.06%760M | 7.21%3.73B | 25.41%997M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -42.79%-861M | 112.23%86M | -8.68%-739M | 1.85%-2.76B | -1.57%-778M | 12.48%-603M | 5.38%-703M | -10.03%-680M | -64.58%-2.82B | 1.79%-766M |
| Capital expenditure reported | -28.13%-943M | -14.04%-934M | -14.97%-837M | -2.85%-3.17B | -3.48%-891M | 4.17%-736M | -6.50%-819M | -5.81%-728M | -1.21%-3.09B | 3.37%-861M |
| Net PPE purchase and sale | --0 | -71.43%2M | ---- | 46.15%19M | 100.00%10M | 0.00%2M | 133.33%7M | --0 | -85.23%13M | -61.54%5M |
| Net business purchase and sale | ---1M | 9,181.82%999M | --0 | ---59M | ---4M | --0 | ---11M | ---44M | --0 | --0 |
| Net investment purchase and sale | --0 | --0 | ---- | 521.74%97M | 176.92%20M | 1,366.67%44M | --33M | ---- | -106.04%-23M | -2,500.00%-26M |
| Dividends received (cash flow from investment activities) | 65.79%63M | 26.19%53M | -19.15%38M | -27.47%198M | -37.72%71M | -48.65%38M | 133.33%42M | -29.85%47M | -68.58%273M | 15.15%114M |
| Net other investing changes | -59.18%20M | -175.56%-34M | 33.33%60M | 2,114.29%155M | 700.00%16M | --49M | 800.00%45M | --45M | --7M | --2M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -42.79%-861M | 112.23%86M | -8.68%-739M | 1.85%-2.76B | -1.57%-778M | 12.48%-603M | 5.38%-703M | -10.03%-680M | -64.58%-2.82B | 1.79%-766M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -234.63%-1.3B | -99.17%-721M | -54.58%-439M | -48.96%-1.8B | -122.81%-762M | -16.22%-387M | -17.15%-362M | -28.51%-284M | 53.73%-1.21B | 58.04%-342M |
| Net issuance payments of debt | 25.00%-3M | -400.00%-3M | 110.00%1M | 322.22%38M | 145.00%49M | -33.33%-4M | -94.12%1M | -162.50%-10M | 104.13%9M | 107.04%20M |
| Net common stock issuance | -520.00%-589M | -446.94%-268M | ---143M | ---498M | ---354M | ---95M | ---49M | --0 | --0 | --0 |
| Cash dividends paid | -45.98%-254M | 2.86%-170M | 1.71%-172M | 0.57%-696M | 2.27%-172M | 0.57%-174M | -0.57%-175M | 0.00%-175M | 38.76%-700M | 32.57%-176M |
| Net other financing activities | -293.86%-449M | -101.44%-280M | -26.26%-125M | -24.32%-639M | -53.23%-285M | 26.45%-114M | 8.55%-139M | -59.68%-99M | 37.24%-514M | -16.25%-186M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -234.63%-1.3B | -99.17%-721M | -54.58%-439M | -48.96%-1.8B | -122.81%-762M | -16.22%-387M | -17.15%-362M | -28.51%-284M | 53.73%-1.21B | 58.04%-342M |
| Net cash flow | ||||||||||
| Beginning cash position | 18.98%4.8B | 4.21%4.11B | -1.78%4.07B | -6.58%4.15B | -0.84%4.23B | -2.91%4.04B | -9.94%3.94B | -6.58%4.15B | -15.91%4.44B | -18.68%4.26B |
| Current changes in cash | 40.00%266M | 638.30%694M | 116.67%34M | 76.47%-68M | -33.33%-148M | 80.95%190M | 142.73%94M | -223.81%-204M | 65.35%-289M | 86.13%-111M |
| Effect of exchange rate changes | 200.00%1M | --0 | --0 | -100.00%-6M | -50.00%-3M | 0.00%-1M | --0 | ---2M | 50.00%-3M | ---2M |
| Cash adjustments other than cash changes | ---- | ---- | ---4M | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| End cash Position | 19.98%5.07B | 18.98%4.8B | 4.11%4.1B | -1.78%4.07B | -1.78%4.07B | -0.84%4.23B | -2.91%4.04B | -9.94%3.94B | -6.58%4.15B | -6.58%4.15B |
| Free cash from | 233.11%1.48B | 16.18%395M | 1,071.88%375M | 103.87%1.32B | 268.38%501M | 23.68%444M | 439.68%340M | -63.64%32M | 49.54%646M | 241.67%136M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.